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MicroRNAs (miRNAs) have recently become essential actors in various ﬁelds of physiology
and medicine, especially as easily accessible circulating biomarkers, or as modulators of
cell differentiation.To this respect, terminal differentiation of trophoblasts (the characteristic
cells of the placenta in Therian mammals) into syncytiotrophoblast, villous trophoblast,
or extravillous trophoblast constitutes a good example of such a choice, where miRNAs
have recently been shown to play an important role. The aim of this review is to provide a
snapshot of what is known today in placentationmechanisms that are mediated bymiRNA,
under the angles of materno–fetal immune dialog regulation, trophoblast differentiation,
and angiogenesis at the materno–fetal interface. Also, two aspects of regulation of these
issueswill be highlighted: the part played by oxygen concentration and the speciﬁc function
of imprinted genes in the developing placenta.
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INTRODUCTION
Mammalian pregnancy rests on a biological paradox: the intimate
entangling of two different immunological systems during a long
period of gestation (Medawar, 1961). In many species of mam-
mals, the blastocyst enters the endometrial part of the uterus,
during an invasive process occurring at the hatching of the blas-
tocyst (4.5 days post coitum in mice, 7 days in humans). In
humans, the external layer of the blastocyst (trophectoderm) pro-
liferates, its outer cells syncytialize and lacunae form, deﬁning
digitations of the trophectoderm that form columns (primary
chorionic villi). During the ﬁrst trimester the existing structures
persist and develop to form the ﬂoating villi of the placenta, while
trophoblast cells that are not part of the villi form plugs sealing the
intervillous space, and prevent maternal blood cells from being in
contact with the syncytiotrophoblast (Carbillon et al., 2001). From
the eighth and ongoing till at least the 16th week of gestation, the
plugs begin to disappear, extravillous trophoblasts (EVTs) invade
the uterine matrix, some going inside the decidua (interstitial
trophoblasts), some fusing in a fashion similar to the syncytiotro-
phoblast (leading to placental bed giant cells), some replacing the
maternal arteries endothelium in an ill-understood substitution
process (endovascular trophoblasts), as depicted in Figure 1. The
invasion of maternal tissue by trophoblast-derived cells is a speciﬁc
and constant feature of human placentation (Goldman-Wohl and
Yagel, 2002; Carter and Mess, 2007). Unsuccessful invasion is now
recognized to lead to pregnancy diseases, such as preeclampsia
(PE). PE is deﬁned by a gestational hypertension accompanied by
proteinuria that develops from the 20th week of gestation (Sibai,
2005). This disease has a prevalence estimated at ∼3–7%, threat-
ens the life of the mother and the fetus and its symptoms worsen
from the appearance of the symptoms till the end of pregnancy.
Delivery is the only real cure of this disease, which incidently is
a major cause of iatrogenic prematurity. Genetic and epigenetic
causes have been ascribed to PE (Chelbi and Vaiman, 2008).
The cells that compose these different structures derive from
trophoblast stem cells, the fate of which has been particularly
well-characterized in mice, and elegantly reviewed in Maltepe
et al. (2010). This latter review emphasizes the involvement of
epigenetic regulators in placental cell differentiation, such as DNA
(cytosine-5)-methyltransferase 3-like (DNMT3L), various histone
deacetylases (HDACs), suppressor of zeste 12 homolog (SUZ12).
miRNAs are also important elements of the cell epigeneticmachin-
ery. Contrary to the other known players of epigenetic regulation,
DNA methylation and post-translational histone modiﬁcations,
they are able to affect gene expression after transcription by mod-
ulating mRNA stability and/or translation. The miRNAs achieve
their epigenetic action by negatively modulating series of genes
by targeting mRNA regulatory sequences often located in the 3’-
untranslated sequence. Speciﬁcally, miRNAs are short (mean 22
nucleotides) ribonucleic acid (RNA) molecules. They are encoded
by nuclear genes whose transcripts (called pri-miRNA) are pro-
cessed in the nucleus to form pre-miRNAs through the action of
the protein Drosha, or are part of introns that are also processed
to form pre-miRNAs. Then, after export to the cytoplasm they
are matured as miRNAs through the action of the protein Dicer
through the RNA-induced silencing complex (RISC).
In the past 3 years, miRNAs have acquired a strong position
in the list of factors inﬂuencing the different facets of trophoblast
biology, such as proliferation, syncytialization, and invasion. A
direct consequence, their impact on the major human placen-
tal diseases, such as PE, intra uterine growth restriction (IUGR,
the failure of the fetus to reach a normal growth curve) or pla-
centa accreta (a very severe obstetric disease where the placenta
implants through the endometrium, and considerably increases
the risk of hemorrhage at delivery) has also been revealed. A
PubMed search for the keywords “miRNA” and “trophoblast” or
“placenta,” yields 137 results, the ﬁrst paper having been pub-
lished in 2006. One seminal study that set the de novo landscape
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FIGURE 1 |This figure summarizes simplistically some of the features
of trophoblast fate that are at least partly governed by miRNA
expression. Trophoblast cells are represented in blue with a round
nucleus. Trophoblasts (in blue) can proliferate (left part of the ﬁgure) or
differentiate into syncytiotrophoblast (right part of the ﬁgure; in this case,
nuclei are ﬁlled in purple) or into endovascular or interstitial trophoblast in
the vascular context of maternal arteries (represented as a cone in the
lower part of the ﬁgure; in this case the nuclei are represented in light
blue). In this latter case, they eventually become enclosed into the arterial
wall to become intramural trophoblast along pathways that are still
debated as nicely described by Pijnenborg et al. (2006). In the ﬁgure,
crucial genes for cell cycle, Nodal, Notch, and FGF pathways, ROS
production, invasion, and angiogenesis are presented in red. Crucial
miRNAs are in blue. Blue arrows represent cell differentiation/proliferation
pathways. Black arrows symbolize induction. When black lines are
terminated by an orthogonal bar they represent inhibition. In the cases
where the relation is not fully demonstrated, dotted arrows are used. It is
clear that this vision is far from exhaustive, but attempts to depict current
knowledge on the role of miRNA in building placental structure and
ensuring efﬁcient vascularization of this organ.
of miRNA-regulation in cells of the trophoblast lineage, was
published in 2012 by Morales-Prieto et al. (2012). There, the
authors screened 762 human miRNAs for their expression level
in term and ﬁrst trimester cytotrophoblasts, as well as in four
cell lines: HTR8/SVneo (a cell line generated by transformation
of an EVT), JEG-3 (a trophoblast-like line derived from a chori-
ocarcinoma), ACH-3P and AC1-M59, the two latters consisting
of choriocarcinoma fused either with early or late trophoblasts,
respectively. One of the major outcomes of this work was the
identiﬁcation of clusters of placenta-speciﬁc miRNAs (C19MC,
54 miRNAs on chromosome 19, C14MC, 34 miRNAs on chromo-
some 14, and another minor cluster on chromosome 19). Their
study also identiﬁed 27miRNAs differentially expressed according
to trophoblast age. Therefore this study gives an indicative ency-
clopedia of miRNAs susceptible to play an important role in the
trophoblast.
In the present review, we will try to identify in the available
literature the miRNAs that are known to be the major players of
trophoblast function, in terms of (1) materno–fetal dialog leading
to tolerance, (2) major differentiation events leading to syncy-
tiotrophoblast generation from trophoblast cells, (3) angiogenesis
and vasculogenesis in normal and pathological conditions, (4)
impact of oxygen sensing, and (5) known links between miRNA
and imprinted genes, since many of them are involved in pla-
cental function (Varrault et al., 2006; Renfree et al., 2013). We
will mainly focus on those miRNAs for which validated gene tar-
gets have been identiﬁed. The orchestrator function of hypoxia
in placental development will also be evoked. A limited number
of miRNAs important for placental physiology are presented in
Figure 1 and some of them are summarized in Table 1. The clas-
sical mechanisms of miRNA production andmaturation, through
the action of Drosha or Dicer for instance, are beyond the scope of
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Table 1 | Summary of some miRNAs discussed in the text and of their known function in placental physiology.
miRNA Targets Biological role Reference
miR-152 HLA-G Materno–fetal immune dialog Tan et al. (2007), Kulkarni et al. (2011), Manaster
et al. (2012)
miR-148 HLA-G, HLA-C Syncytialization Kumar et al. (2013)
miR-106a hCYP191A1, hCGB, GCM1
miR-19b hCYP191A1, hCGB, GCM1
miR-17, miR-20a, miR-20b EPHB4, EFNB2 Spiral arteries remodeling,
vasculogenesis, TGFβ signaling
Wang et al. (2012), Chen andWang (2013)
miR-34a Notch1, Jagged1 Pang et al. (2010)
miR-210 HOXA9, EPHA3 Pineles et al. (2007), Zhang et al. (2012)
miR-27b Delta4, Spry2 Biyashev et al. (2012)
miR-126 SPRED1 Yan et al. (2013)
miR-29 MCL1, MMP2, VEGFA, ITGB1 Li et al. (2013b)
miR-378a-5p Nodal Luo et al. (2012)
miR-376c ALK5/ALK7 Fu et al. (2013b)
miR-21 Oxygen sensing Cindrova-Davies et al. (2013)
miR-548c Ishibashi et al. (2012)
miR-205 MED1 Mouillet et al. (2010)
miR-424 FGFR1 Mouillet et al. (2013)
miR-21 SP1 Cindrova-Davies et al. (2013)
miR-210 ISCU1/2, COX10, HSD17B1 Pineles et al. (2007), Chen et al. (2010),
Enquobahrie et al. (2011), Mayor-Lynn et al. (2011)
miR-518c HSD17B1 Ishibashi et al. (2012)
cluster C19M General pathways of development,
differentiation and cell cycle
Imprinting Flor et al. (2012)
miR-379 DIO3
miR-431, miR-127, miR-136 RTL1 Girardot et al. (2012)
miR-675 Igf1R, NOMO1 Munir et al. (2004), Gao et al. (2012), Keniry et al.
(2012)
this review, although the description of the effects of Dicer inhi-
bition on placental development will be mentioned. To obtain a
clear vision of the mechanisms of miRNA maturation, the reader
can consult the recent review from Chen andWang (2013).
miRNAs AND REGULATION OF THE MATERNO–FETAL
IMMUNE DIALOG
Implantation of the blastocyst occurs at 4.5 dpc in mice and at 7
dpc in humans. At this stage, the blastocyst establishes a physical
contact with the endometrium during the implantation window.
Hatching of the blastocyst allows the primary immunological con-
tact between the fetal antigens and the maternal immune system.
The conundrum of fetal non-rejection has been underlined by
Peter Medawar as early as in the 1950s (Billington, 2003). One ele-
ment of the solution is provided by the fetal expression of a limited
antigen repertoire, since contrary tomost cells of the human body,
trophoblasts do not express human leukocyte antigen (HLA)-A
and -B, the major histocompatibility (MHC) antigens that are
highly polymorphic. Trophoblast cells express HLA-G (ﬁve alle-
les only; Hunt et al., 2006; one mRNA spliced in seven isoforms;
Geraghty et al., 1987; Hunt et al., 2007) and HLA-C (two major
alleles; Hiby et al., 2004; Moffett and Loke, 2006). Trophoblasts
interact with uterine natural killer cells through their killer-cell
immunoglobulin-like receptor (KIR) receptors (Hiby et al., 2010),
two major forms of which exist (KIR-A and KIR-B). Some com-
binations of KIR and HLA-C have been shown to predispose
to PE, but overall, the system is tuned to allow tolerance. To
note, in recent years, HLA-G has been considered as a general
immune-tolerogenic molecule in various tissues (Wiendl et al.,
2005; Carosella, 2011; Gonzalez et al., 2012). HLA-G is expressed
by EVT, and its expression has been found regulated bymiR-152 in
the context of asthma (Tan et al., 2007). More recently, Manaster
et al. (2012) showed that in EVT,HLA-GmRNA is targeted as well
by miR-148, and this irrespectively to a speciﬁc single nucleotide
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polymorphism (SNP) located in the 3’-untranslated region (UTR)
of HLA-G. This down-regulation is associated with an enhanced
killing activity of natural killer (NK) cells. Very recently, it has
been shown that in CD4+ T lymphocytes, soluble HLA-G mod-
ulates the expression of miRNA-451 and miRNA-210 (Morandi
and Pistoia, 2013). These sets of results are extremely important
in the context of human pregnancy. Among CD4+ T uterine lym-
phocytes, a small proportion (∼5%) consists in Treg cells. These
cells when maturated in peripheral organs, especially in uterine
tissue, are key elements for a successful placentation in placen-
tal mammals (Samstein et al., 2012). HLA-C is also targeted by
miRNAs, especially miR-148 (Kulkarni et al., 2011) although the
impact of this regulation has mainly been studied in the context
of HIV infection with the description of a sensibility-modulating
SNP in the 3’-UTR of the gene. This regulation of HLA-C by
miRNA has not been studied in the trophoblast context, neverthe-
less it is strongly expressed in cells of trophoblast origin (Manaster
et al., 2012), suggesting that it may play a role in the expression
of this antigen. To summarize, miRNAs appear as able to modu-
late very early the immunological balance of the uterine–embryo
contact.
miRNAs AND THE TROPHOBLAST–SYNCYTIOTROPHOBLAST
TRANSITION
Besides these very early effects on trophoblast biology, miRNAs
have recently been shown to play extensive roles on the fate
of trophoblasts. One of them is the evolution into syncytiotro-
phoblast. In fact near the end of pregnancy, villous trophoblasts
become very rare, limiting the rejuvenation capability of the syncy-
tiotrophoblast (Rigourd et al., 2009). Recently, Kumar et al. (2013)
interrogated by microarray analysis the developmental transition
leading to syncytiotrophoblast differentiation. In this study, the
authors identiﬁed miRNAs belonging to three clusters modiﬁed
during trophoblast differentiation (miR-17, 20a, 20b, 19b belong-
ing to the miR-17∼92 cluster, on chromosome 13q31; miR-106a,
on chromosome X, belonging to cluster 106a∼363, and miR-
93, on chromosome 7, belonging to the miR 106b∼25 cluster).
These miRNAs are all down-regulated in syncytiotrophoblast.
miR-106a andmiR-19b directly target the 3’-UTRof the aromatase
(hCYP19A1) gene. Aromatase is expressed in the syncytiotro-
phoblast exclusively. One of themost interesting targets discovered
by the authors is glial cell missing homolog1 (GCM1), a transcrip-
tion factor playing a major function in trophoblast differentiation
and fusion (Anson-Cartwright et al., 2000), also known to be
down-regulated in PE, one of themost important diseases of preg-
nancy (Chen et al., 2004; Chiang et al., 2009; Drewlo et al., 2011;
Wilson et al., 2011). GCM1 expression is also reduced fourfold in
JEG-3 cells overexpressing STOX1 that share strong transcriptomic
characteristics with the human preeclamptic placenta (Rigourd
et al., 2008, 2009). Interestingly, one of the most classical mark-
ers of syncytialization, human chorionic gonadotrophin (hCGβ),
was also decreased by miR-19b and miR106a; in the absence of
predicted bona ﬁde target in the gene, it was shown that this
results from an indirect action of GCM1 (Kumar et al., 2013).
In the same study the authors show that c-Myc binds directly
to the 5’ upstream region of the clusters miR-17∼92 and miR-
106a∼363, the expression of this protooncogene being decreased
during syncytiotrophoblast differentiation. These novel mecha-
nistic data especially on the miR-17∼∼92 and miR-106a∼363
clusters, strengthen recent observations published by Wang et al.
(2012) that show up-regulation of miR-17, miR-20a (belong-
ing to miR-17∼92) and miR-20b (belonging to miR-106a∼363)
in preeclamptic placentas, which as mentioned in the introduc-
tion is a disease generally caused by trophoblast dysfunction
and presumably associated to a generalized activation of the
endothelium.
miRNAs, ANGIOGENESIS, AND VASCULOGENESIS AT THE
UTERO-PLACENTAL INTERFACE: REGULATION OF THE NOTCH
PATHWAY AND LINKS WITH PREECLAMPSIA
A key event in early placentation involves the remodeling of the
uterine spiral arteries by migrating EVTs a process known as
pseudovasculogenesis or vascular mimicry (Ji et al., 2013). This
process transforms the uterine spiral arteries from high resis-
tance, low ﬂow muscular vessels to low resistance, and high ﬂow
vessels enabling them to ensure proper irrigation to the devel-
oping placenta/fetus. It has been consistently reported that in
early onset PEs (generally the most severe) the remodeling of the
spiral arteries is impaired (Red-Horse et al., 2004). This leads to
reduced perfusion of the developing placenta, subsequent inter-
mittent hypoxia-reoxygenation episodes, reactive oxygen (ROS)
production, cell injury, inﬂammation, and liberation of placen-
tal factors and debris into the maternal circulation. Spiral artery
remodeling appears to be a multi-stage process involving: spiral
arteries preliminary remodeling (characterized by vacuolization
and apoptosis of resident ECs), EVTs migration and invasion of
the decidua andmyometrium, incorporation of EVTs into the spi-
ral arteries vessel walls, and acquisition by the endovascular EVTs
of an EC-like phenotype. The trans-differentiation of EVTs into
EC-like cells (vascular mimicry) results in the down-regulation
of epithelial cell-type markers E-cadherin and integrin α6β4 and
the induction of the expression of endothelial adhesion molecules
such VE-cadherin, PECAM, NCAM as well as integrins α5β1,
α1β1, αVβ3 (Damsky and Fisher, 1998).
Experimental evidence of the implication of miRNAs in the
different stages of spiral arteries remodeling and their eventual
dysfunction inPE is still limited. A recently published study reports
an increased expression of members of the miR-17 family miR-
NAs (miR-17, miR-20a, and miR-20b) in PE versus normotensive
human placentas (Wang et al., 2012). Among the potential targets
of the miR-17 family miRNAs the authors identiﬁed the ephrin
receptor B4 (EPHB4) and ephrin B2 (EFNB2), two Eph receptor
tyrosine kinases involved in angiogenesis (Wang et al., 1998). In the
placenta, the couple EFNB2/EPHB4 directs EVTs invasion away
from the placenta and towards uterine spiral arterioles (Red-Horse
et al., 2005). The same authors found that the forced expression
of miR-20a in BeWo cells (a human cell line derived from a pla-
cental choriocarcinoma) inhibits syncytialization and induces the
expression of ECs markers. Therefore, it has been postulated that
in normal placentation low levels of miR-17 family miRNAs allow
a higher expression of EFNB2/EPHB4 in the EVTs facilitating the
invasion and uterine spiral arteries remodeling. Ephrin receptors
B2 and B4 are receptor tyrosine kinases and several reports sug-
gest their involvement in cell differentiation mechanisms (Adams,
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2002). They are also involved in vascular endothelial growth factor
(VEGF)-mediated angiogenic functions through regulation of sig-
naling of the VEGFR2 and VEGFR3 receptors in endothelial cells
(Sawamiphak et al., 2010; Wang et al., 2010). In PE, an increased
expression of miR-17 family members would suppress the expres-
sion of EFNB2/EPHB4 resulting in inhibition of spiral arteries
invasion and endovascular EVTs differentiation (Chen andWang,
2013).
Recent studies have implicated the Notch pathway in the
process of spiral arteries remodeling and in the pathogenesis
of PE (Hunkapiller et al., 2011). This is in good accordance
with the known role of Notch signaling in vascular patterning
and in the speciﬁcation of arterial identity (Roca and Adams,
2007; Swift and Weinstein, 2009). The core component of this
pathway consists of four transmembrane receptors (Notch1–4)
and ﬁve ligands (Delta1/3/4 and Jagged 1/2) that are dynami-
cally expressed through placental development (Hunkapiller et al.,
2011). Conditional deletion of Notch2 in mice leads to signif-
icant reduction in placental perfusion and arterial invasion by
trophoblasts (Gasperowicz and Otto, 2008). Also, when human
cytotrophoblasts are grown on Matrigel, NOTCH promotes their
invasion and acquisition of an arterial EC-like phenotype marked
by EFNB2 up-regulation (Gasperowicz and Otto, 2008). More-
over, signiﬁcant JAGGED1 down-regulation in the perivascular
and endovascular EVTs has been detected in PE, and found to be
associatedwith failed vascular remodeling (Gasperowicz andOtto,
2008). Interestingly, overexpression of miR-34a in the choriocar-
cinoma cell line JAR (derived from a trophoblastic tumor of the
placenta) inhibits cell invasion by targeting Notch1 and Jagged1
(Pang et al., 2010). This suggests a possible role of miRNAs in the
regulation of Notch signaling in the early stages of uterine inva-
sion and spiral arteries remodeling. Recently, we have shown that
while pri-miR-34a is overexpressed twice inpreeclamptic placentas
(where the gene promoter is demethylated), the mature miR-34a
is present at a much lower level in pathological placentas than
in normal placentas (Doridot et al., 2013). Our data suggest that
this mechanism could contribute to an indirect up-regulation of
SERPINA3 in pathological pregnancies (Chelbi et al., 2007, 2012),
this gene being an important actor of placental homeostasis and
trophoblast invasion.
Many other miRNAs are known to be involved in the regula-
tion of Notch signaling. Among these,miR-30 targets DLL4 (delta
like ligand-4; Bridge et al., 2012), and miR-210 over-expression
in ECs causes up-regulation of Notch1 and induces migration
and tube formation in Matrigel (Lou et al., 2012). Interestingly,
miR-210 is known to be one of the most up-regulated miRNAs
in the preeclamptic placenta and has been involved in trophoblast
migration and invasion process (Pineles et al., 2007; Zhang et al.,
2012). Another recent study has shown that miR-27b controls two
critical vascular functions in zebraﬁsh: it turns on the angiogenic
switch by promoting endothelial tip cell fate and sprouting and
it promotes venous differentiation. The Notch ligand Delta4 and
Sprouty homolog 2 (Spry2) were identiﬁed as miR-27b targets
involved in these functions. Moreover, miR-27b is necessary for
the formation of the ﬁrst embryonic vein in ﬁsh and controls
the expression of arterial and venous markers in human endothe-
lium, including EFNB2, EPHB4, fms-related tyrosine kinase 1
(Flt1), and fms-related tyrosine kinase 4 (Flt4; Biyashev et al.,
2012). Also, in vascular smooth muscle cells (VSMCs) Notch
signaling through Jagged1 promotes a differentiated phenotype
characterized by an increased expression of contractile proteins,
this effect being mediated through the induction of miR-143/145
transcription (Boucher et al., 2011). Finally, severalmiRNAs (miR-
9, miR-21, miR-27, miR-124, miR-130, miR-148, and miR-181)
involved in vascular development and ECs signaling have been
predicted to target components of the Notch pathway (Anand,
2013). Therefore, miRNAs regulation of Notch signaling might
play an important role in placental angiogenesis.
In a larger context, the importance of miRNAs in angiogenesis
and ECs physiology has been established by the study of Dicer
inactivation. Thus, Dicer hypomorphic mice present severely
impaired vascular development in both the embryo and yolk sac
(Yang et al., 2005). Endothelial speciﬁc deletion of Dicer in mice
decreases postnatal angiogenesis (Suarez et al., 2008). Also,VSMCs
inducible deletion of Dicer in mice, leads to impaired differen-
tiation, contractility, and vascular remodeling (Albinsson et al.,
2011). Altogether, these studies point out to the essential role
of Dicer and hence of miRNAs for the proper development and
function of vascular cells. The analysis of the miRNAs expressed
in HUVECs has allowed identifying miRNAs involved in ECs
function (Poliseno et al., 2006). Among these miR-126 has been
found as one of the most abundantly expressed in ECs (Fish et al.,
2008; Wang et al., 2008). This miRNA is essential for angiogen-
esis and targets Sprouty related EVH domain containing protein
1 (SPRED1), a negative regulator of vascular endothelial growth
factor 1 (VEGF). Owing to its role in endothelial progenitor cells
(EPCs) physiology, a recent study has suggested that miR-126 is
essential for placental vasculogenesis and suggested that it could
provide a therapeutic approach for PE (Yan et al., 2013). Another
study has shown that miR-29 induces apoptosis and inhibits the
invasive and angiogenic capacities of trophoblast cell lines (HTR-
8/SVneo, BeWo, and JAR). This study has shown that miR-29b
regulates the expression of myeloid cell leukemia sequence 1
(MCL1), matrix metalloproteinase 2 (MMP2), vascular endothe-
lial growth factor A (VEGFA), and integrin β1 (ITGB1) genes by
directly binding their 3’-UTRs. Moreover, an inverse correlation
was detected between miR-29b and the expression levels of these
targets genes in PE (Li et al., 2013b).
In conclusion, to date many miRNAs have been found to play
important roles in the regulation of angiogenesis and ECs home-
ostasis (Hartmann and Thum, 2011; Small and Olson, 2011),
an issue indirectly linked to trophoblast differentiation. Indeed,
oxygen availability or scarceness are landmark morphogens for
trophoblast cell fate.
Despite an increasing number of studies seeking to identify
miRNAs involved in the pathogenesis of PE, only a few of them
have been associated to the essential process of placental angio-
genesis, and in particular to its earliest steps (Fu et al., 2013a).
In humans, the analysis of the role of miRNAs in spiral arteries
remodeling is complicated due to the difﬁculty to access to pla-
cental tissue for experimental purposes. Therefore, it is likely that
further studies will be greatly dependent on animal models (i.e.,
mice), but also, owing to the particularities of human placenta-
tion, on the development of in vitro models able to reproduce the
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different stages and cellular interactions (cell contacts, cytokines
signaling, miRNA exchanges mediated by exosomes, etc.) which
are likely involved in spiral artery transformation.
miRNAs AND OXYGEN SENSING AT THE TROPHOBLAST
LEVEL
Hypoxia is a key signal for normal placental development in
physiological pregnancy, and has a crucial role in the control
of trophoblast differentiation into invasive or proliferating cells
(Zhou et al., 1997; Jauniaux et al., 2003). Heretofore, its effect
was primarily described as mediated through HIF transcription
factors, but recently, it was recognized that miRNAs induced by
hypoxia could participate by regulating genes that are not directly
hypoxia-inducible (Huang et al., 2009). Hypoxia-inducible miR-
NAs constitute a new group of genes that could be important for
trophoblast differentiation. To identify such miRNAs, trophoblast
cells puriﬁed from term placentas were grown in normoxia or
hypoxia (48 h, 1%O2), andmiRNAs expression proﬁlewas studied
by microarray and Northern blot (Mouillet et al., 2010). Among
the most highly expressed miRNAs, seven miRNAs were shown
modiﬁed in hypoxia: miR-93, miR-205, miR-224, miR-335, miR-
424, miR-451, and miR-491. Other miRNAs induced by hypoxia
were identiﬁed by targeted approaches, as they were shown to
be modiﬁed in preeclamptic placentas (considered as hypoxic)
or pregnancies associated with abnormal placental Doppler wave-
forms, indicative of a blood circulation defect; this was the case for
miR-21 (Cindrova-Davies et al., 2013), miR-210 (Ishibashi et al.,
2012; Lee et al., 2012; Muralimanoharan et al., 2012), and miR-
518c (Ishibashi et al., 2012). These hypoxia-inducedmodiﬁcations
in miRNA content are probably not linked to miRNAs biogene-
sis, since the responsible enzymes are apparently not modiﬁed by
hypoxia (Donker et al., 2007).
For some of these candidate miRNAs, their potential involve-
ment in trophoblast function and/or differentiation was assessed
thanks to the identiﬁcation of their target genes. miR-205 con-
centration is increased in hypoxic conditions (around twice after
48 h at <1% O2) in primary trophoblast cells and miR-205 tar-
gets MED1, as validated by luciferase assay (Mouillet et al., 2010).
MED1 is an important regulator of murine placental develop-
ment (Landles et al., 2003), that regulates the expression of hCG,
human placental lactogen (hPL), and placental-speciﬁc protein 1
(Plac1) in primary trophoblast cells (Mouillet et al., 2010). miR-
424 is down-regulated around ﬁvefold following 72 h of hypoxia
in primary trophoblast cells (but not in the trophoblast cell line
JEG-3). It targets FGFR1 as demonstrated by luciferase assay
(Mouillet et al., 2013). FGF signaling has been implicated through-
out development in many signaling pathways controlling cellular
proliferation, differentiation, survival, and angiogenesis (Turner
et al., 2010). FGFR1 role in pregnancy is however unclear, since
its deletion in mice is embryonically lethal around E7.5–E9.5, pre-
venting a detailed analysis of its role in the placenta (Deng et al.,
1994; Yamaguchi et al., 1994). miR-424 amounts are also restricted
by other signals inhibiting differentiation (in syncytiotrophoblast
cells), such as dimethyl sulfoxide (Mouillet et al., 2013). In the
same article, miR-503, localized near miR-424 on chromosome X,
was shown to exhibit the same expression proﬁle in primary tro-
phoblast cells, suggesting the existence of a polycistronic precursor
containing both miRNAs. miR-21 is elevated in placentas with
abnormal Doppler waveforms (IUGR or preeclamptic) compared
to control or preeclamptic placentas with normal Doppler wave-
forms (around twice; Cindrova-Davies et al., 2013). Furthermore,
in placental explant submitted to 3 h of hypoxia (0.5% O2) fol-
lowed by 20 h at 10%O2 in order tomimic hypoxia/reoxygenation
injury, there is an up-regulation of miR-21 (1.6-fold). ThismiRNA
was shown to directly target SP1, which in turn controls the
expression of cystathionine-γ-lyase (CSE), responsible for hydro-
gen sulﬁde (H2S) synthesis (Yang et al., 2012). Yet H2S is thought
to have a vasodilator effect, which could be important for a correct
placentation. This is substantiated by the decreased expression
of CSE in placentas with abnormal Doppler waveforms, and in
the placental explant submitted to hypoxia/reoxygenation injury
(Wang et al., 2013b). To note, SP1 a zinc ﬁnger transcription factor
is recurrently found important in placental physiologymodulation
(Gascoin-Lachambre et al., 2010; Chelbi et al., 2012; Vaiman et al.,
2013). miR-21 could have other effects on trophoblast function in
terms of proliferation, since it has been described as a pro-invasive
oncogene in breast cancer (Xu et al., 2008). miR-210 is probably
the miRNA for which there is the most abundant literature in
relation with placental hypoxia. Actually, it was one of the ﬁrst
identiﬁed hypoxia-up-regulated miRNAs, principally in the con-
text of tumors (Kulshreshtha et al., 2007). Since then,miR-210 was
shown to be induced by hypoxia in a vast number of cell types (Hsu
et al., 2012), leading to rename it “hypoxamiR.”miR-210 was also
found affected in every miRNA screen comparing preeclamptic
and normal placentas (Pineles et al., 2007; Santner-Nanan et al.,
2009; Enquobahrie et al., 2011; Mayor-Lynn et al., 2011). miR-
210 targets notably iron sulfur cluster scaffold proteins (ISCU1/2;
Chan et al., 2009; Chen et al., 2010) and cytochrome c oxidase
assembly protein (COX10; Chen et al., 2010). ISCU1/2 facilitate
the assembly of iron-sulfur clusters, prosthetic groups that are crit-
ical for electron transport andmitochondrial oxidation–reduction
reactions, while COX10 is essential for the assembly of electron
transport system complexes I and IV showing how miR-210 may
strongly impact mitochondrial function. Colleoni et al. (2013)
conﬁrmed recently that such mitochondrial alterations occur in
trophoblast cells by cultivating JEG-3 cells for 4 days in hypoxia
(1% O2) and using high altitude placentas, in which miR-210 is
around twice higher than in sea-level placentas, demonstrating
a diminished protein level for complexes I and IV. Mitochon-
drial function following miR-210 induction by hypoxia was also
assessed in preeclamptic placentas and primary trophoblast cells
isolated from control placentas (Muralimanoharan et al., 2012).
In this latter study, the authors demonstrated mitochondrial
dysfunction in placentas from pregnancies complicated by PE,
associated with elevated ROS production and HIF-1α stabiliza-
tion, up-regulation of miR-210 and down-regulation of ISCU.
They demonstrated that increased miR-210 is necessary and suf-
ﬁcient for explaining the observed mitochondrial dysfunction, by
using gain of function and loss of function approaches. miR-
210 effect on iron metabolism could also impact the invasive
capacity of trophoblast as suggested by a decreased invasion of
human ﬁrst-trimester trophoblast cells in MatrigelTM following
ISCU knock-down (Lee et al., 2011). However the invasive defect
following miR-210 expression can also be due to other validated
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targets such as EphrinA3 and HOXA9, both involved in migration
and vascular remodeling (Zhang et al., 2012). In this latter study,
the authors also demonstrated that miR-210 expression is also
regulated by NF-κB (p50 subunit), in addition to HIF1α. MiR-210
also targets hydroxysteroid (17-β) dehydrogenase 1 (HSD17B1),
a steroidogenic enzyme gene predominantly expressed in the pla-
centa, the encoded protein catalyzing the conversion of estrone to
17-β estradiol (Ishibashi et al., 2012). This gene is also the target
of miR-518c, anothermiRNA expressed in the syncytiotrophoblast
layer of the placenta. These twomiRNAswere found by comparing
miRNA proﬁle from normal and preeclamptic placentas, by high
throughput sequencing and qPCR. Luciferase assays conﬁrmed
HSD17B1 as a genuine target of miR-210. miR-518c and miR-210
were then assessed in JEG-3 and BeWo cells exposed to hypoxia
(1% O2) and demonstrated to be induced. This study led to pro-
pose to use HSD17B1 as a biomarker, as it was shown reduced
in the plasma from preeclamptic patients, before the onset of the
symptoms. However, how the reducedHSD17B1 could participate
to the physiopathology remains unclear.
For most identiﬁed hypoxia-up-regulated miRNAs in tro-
phoblast cells, there are neither identiﬁed speciﬁc target genes, nor
explanations about a possible involvement in trophoblast cell func-
tion. However, description of some targets found in other cell type
can lead to interesting hypotheses. For example, overexpression of
miR-93 attenuated hypoxia-induced apoptosis in endothelial and
skeletal muscle cells, enhanced proliferation in both cell types, and
enhanced endothelial cell tube formation (Hazarika et al., 2013).
miR-224 was recently shown to target Raf kinase inhibitor pro-
tein (RKIP), a tumor suppressor that protects against metastasis
and genomic instability, and to have a positive effect on Transwell
migration, 3D growth in Matrigel, and wound healing in breast
cancer cell lines, probably through RKIP target genes, notably
MMP1 (Huang et al., 2012). miR-335 overexpression can simulta-
neously suppress the invasiveness of ovarian cancer cells and lung
cancer cells and promote apoptosis of lung cancer cells by targeting
Bcl-w (Cao et al., 2013; Wang et al., 2013a). miR-451 inhibits cell
proliferation in human hepatocellular carcinoma through direct
suppression of IKK-β (via the down-regulation of cyclin D1 and c-
Myc; Li et al., 2013a). Finally,miR-491 is involved in the migratory
capacity of hepatocellular carcinoma cells by inhibition of matrix
metalloproteinases (Yu et al., 2013). In conclusion, all these recent
studies involve hypoxia-up-regulated trophoblast miRNAs in the
control of proliferation,migration, or invasion, all key processes in
trophoblast function. Given the pivotal role of oxygen, playing on
this factor on puriﬁed trophoblast, before or after syncytialization
could help characterizing exhaustively the miRNAs involved and
shed a novel light on the pathways of trophoblast differentiation
in physiology and pathology.
miRNAs AND REGULATION OF IMPRINTED GENES IN
TROPHOBLAST AND PLACENTAL BIOLOGY
The chromosome 19 miRNA cluster that we mentioned in the
introduction (C19MC) is hosted in a 100-kb region located on
human chromosome 19q13 and contains 46 tandemly repeated
miRNAs (Bortolin-Cavaille et al., 2009). The cluster is sub-
mitted to parental imprinting, resulting in the expression of
the primary long transcript exclusively from the paternal copy,
from which introns containing the different miRNAs are spliced
(Bortolin-Cavaille et al., 2009; Noguer-Dance et al., 2010). This
regulation is under the control of a CpG rich region that under-
goes an extensivemethylation only in thematernal gametogenesis,
resulting in the establishment of a differentially methylated region
(DMR) upstream the cluster. Other imprinted genes are located
in the neighborhood of this cluster, including PEG3 and ZNF331.
These C19MC miRNAs are speciﬁc of the primate lineage and
are expressed almost exclusively in embryonic stem cells and the
placenta (Noguer-Dance et al., 2010).
Expression of the C19MC miRNAs can be detected in tro-
phoblastic cells but also in stromal cells where miR-520c-3p,
miR519a-3p, and miR517a-3p are expressed, whatever the gesta-
tional age (Flor et al., 2012). Trophoblastic model cell lines such as
JEG and BeWo seem to express them whereas HTR8 cells mimick-
ing EVTs do not. Some differences can also be observed depending
on the differentiation stage of the cells. The presence of these
miRNAs could also be observed within exosomes, vesicles that
are secreted by the syncytiotrophoblast layer, released in the feto–
maternal circulation and that are likely to participate to exchanges
between the fetus via its placenta, and the mother (Donker et al.,
2012). An abnormal expression of these miRNAs is observed in
some cancers, suggesting an oncogenic function and giving clues
concerning their possible physiological function. For example the
overexpression of a C19MC miRNA, miR-519d, in hepatic can-
cers is associated with an increased proliferation and invasion, by
direct targeting of molecules regulating the cell cycle such as p21,
PTEN,AKT3, and TIMP2 (Fornari et al., 2012). In the developing
placenta, C19MC miRNAs could participate to the trophoblastic
proliferation necessary to constitute a large placenta required in
primates and to the deep invasion of the maternal decidua neces-
sary to establish a correct blood ﬂow to fulﬁll fetal needs. If direct
interactions between the C19MCmiRNAs and proved targets have
not been extensively described, predicted targets indeed belong to
general pathways of development, differentiation and cell cycle.
Within the cluster, seed sequences are mostly shared by the differ-
ent genes (Lin et al., 2010). miR520c-3p seems to be the only one
of the cluster responding positively to hypoxia.
Located within a large imprinted domain on chromosome
14q32, the C14MC cluster contains 53miRNAs tandemly repeated
in two segments overlapping about 40 kb. The region also
shelters the MEG3, DLK1, RTL1, and DIO3 imprinted cod-
ing genes (Morales-Prieto et al., 2012). The C14MC miRNAs
are expressed only from the maternal allele as MEG3 whereas
their neighbor coding genes DIO3, RTL1, and DLK1 are pater-
nally expressed, all under the control of a speciﬁc upstream
DMR. This proﬁle is conserved in the mouse genome and the
cluster appears to be eutherian-speciﬁc. Some C14MC miR-
NAs directly target the nearby imprinted genes DIO3 (miR-379),
RTL1 (miR-431, miR-127, miR-136), suggesting a role in placen-
tal development (Girardot et al., 2012). Indeed, mice null for
Rtl1 or overexpressing it display an abnormal development and
anomalies of the placenta, notably in capillary formation (Sekita
et al., 2008). Their expression seems to be concentrated in the
developing embryo and placenta. Their predicted targets and
expression proﬁles could propose a role in stem cell physiology and
pluripotency.
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The IGF2-H19 locus is a well-deciphered imprinted locus
located on human chromosome 11p15 and murine chromosome
7. While the IGF2 gene codes for the insulin-like growth factor
2, H19 is a large non-coding RNA. Both genes are epigeneti-
cally regulated under the control of a main imprinting control
region (ICR) and in opposite ways: IGF2 is expressed from the
paternal allele while H19 is maternally expressed. If the function
of IGF2 as a fetal and placental growth-promoting factor is well
known, the mechanisms of action of H19 remain less clear. A
tumor-suppressive effect has been observed in mice in a model
of colorectal cancer (Yoshimizu et al., 2008). In particular, 2 miR-
NAs miR-675-5p and miR-675-3p, are produced from the ﬁrst
exon of H19, the region showing the highest conservation within
mammals. Though H19 is widely expressed in various fetal tis-
sues, miR-675 is only abundant and increasingly expressed in
placental tissues, in the labyrinthe from E11,5. The maturation
of miR-675 seems to be blocked in the ﬁrst part of gestation by
the binding of the HuR protein (Keniry et al., 2012). There is an
inverse correlation between the decrease of HuR and the increase
of miR-675 expression, together with the slowing or arrest of pla-
cental growth during gestation time. In particular, Igf1R, the main
receptor of Igf2, is a target of miR-675. The authors hypothe-
sized that miR-675 plays a role in controlling placental growth and
size along gestation and that H19 serves as a reservoir of miR-
675, produced in response to stress or particular needs during
gestation (Keniry et al., 2012). Nodal modulator1 (NOMO1) is a
direct demonstrated target of miR-675 (Gao et al., 2012). Down-
regulation of H19/miR-675 and increased expression of NOMO1
are observed in preeclamptic placentas. NOMO1 participates to
the Nodal signaling pathway involved in trophoblast prolifera-
tion control and apoptosis (Munir et al., 2004). H19 inhibition
in JAR cells resulted in the abolition of apoptosis and prolif-
eration (Yu et al., 2013). Besides the involvement of imprinted
genes in Nodal modulation it is worth mentioning the important
recent ﬁndings of Luo and co-workers, that after identifying a
potential binding site for miR-378a-5p in the 3’ UTR of Nodal,
demonstrated this targeting. Functionally speaking, the authors
showed that overexpression of the pre-miR (miR-378) induces
several enhancements of trophoblast function in HTR8 cells (cell
survival, proliferation, migration, invasion) and outgrowth and
spreading of EVT from ﬁrst trimester placental explants (Luo
et al., 2012). Similarly, the same team showed that miR-376c tar-
gets ALK5 and ALK7 (receptors for transforming growth factor-β
and Nodal, respectively), its overexpression leading to improved
trophoblast“behavior”as that of miR-378a-5p (Fu et al., 2013b). It
is interesting to notice that miR-378a-5p is reduced in PE. Overall,
these results emphasize the role of Nodal signaling in trophoblast
function.
CONCLUSIONS
The number of articles published on miRNA and trophoblast
development has been steadily increasing every year since
2006, to reach 37 in 2012, and 33 in July 2013 when this
review has been written. This increase clearly illustrates the
impact of miRNAs in placental physiology and pathology. The
present review is clearly not exhaustive, mainly because of
space restriction. It nevertheless gives an overview of several
of the major aspects where miRNAs play a physiological role
in placental development and trophoblast differentiation. In
this context, the links between imprinted genes, oxygen sig-
naling, proliferation, angiogenesis, and invasion in connection
with miRNA expression will likely be better understood in the
future.
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